The Brazil generic drug market size reached US$ 21.0 billion in 2023. The market is projected to reach US$ 38.2 billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2023-2032.
Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five years. The high potential of generic drugs is also driven by the fact that despite strong growth in recent years, the penetration of generics still remains low compared to mature markets such as Germany, the United States, the United Kingdom, etc. These factors along with a rising ageing population, increasing prevalence of life style diseases and the significant cost savings achieved from the use of generic drugs are expected to drive this market in the coming years.
The report entitled “Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2023-2032” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil. This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.
Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five years. The high potential of generic drugs is also driven by the fact that despite strong growth in recent years, the penetration of generics still remains low compared to mature markets such as Germany, the United States, the United Kingdom, etc. These factors along with a rising ageing population, increasing prevalence of life style diseases and the significant cost savings achieved from the use of generic drugs are expected to drive this market in the coming years.
The report entitled “Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2023-2032” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil. This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.
Key Questions Answered in this Report:
- What are generic drugs, how are they different from branded drugs?
- How has the generic drug market performed in recent years?
- How have generics performed compared to branded drugs?
- What were the total sales and volumes of generic drugs in Brazil?
- What has been the impact of COVID-19 on the Brazil generic drug industry?
- Who are the key players in Brazil generic drug market?
- What is the structure of the generic drug market in Brazil?
- What is the pricing mechanism of generic drugs in Brazil?
- What is the value chain of generic drugs in Brazil?
- What are the regulations for generic drugs in Brazil?
- How are generic drugs distributed in Brazil?
- How are generic drugs manufactured?
- What are the drivers and challenges in the generic drugs market in Brazil?
Table of Contents
1 Preface3 Executive Summary10 Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain13 Government Policy14 Brazil Generic Drug Market: Key Success Factors15 Brazil Generic Drug Market: Road Blocks17 Brazil Generic Drug Market: Key Company Profiles
2 Scope and Methodology
4 Brazil Generic Drug Market - Introduction
5 Why is the Brazil Generic Drug Market So Lucrative
6 Global Generic Drug Market
7 Brazil Generic Drug Market
8 Brazil Generic Drug Industry: SWOT Analysis
9 Brazil Generic Drug Industry: Value Chain Analysis
11 Brazil Generic Drug Industry: Porter’s Five Forces Analysis
12 Brazil Generic Drug Market: Competitive Landscape
16 Generic Drug Manufacturing Process
List of Figures
List of Tables
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | January 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 21 Billion |
| Forecasted Market Value ( USD | $ 38.2 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Brazil |
